A prognostic test for adenocarcinoma of the lung from gene expression profiling data

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 9, 2003, Pages 905-910

  Gordon, Gavin J ^a   Richards, William G ^a   Sugarbaker, David J ^a   Jaklitsch, Michael T ^a   Bueno, Raphael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GENE PRODUCT; GLUCOSE TRANSPORTER 1; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE STIMULATING 1 RECEPTOR; PROTEIN FXYD3; PROTEIN S 100; PROTEIN S 100P; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TECHNIQUE;

ADENOCARCINOMA; BREAST NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0141452074     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mountain, C. F. Revisions in the international system for staging lung cancer. Chest, 111: 1710-1717, 1997.
2. Fraire, A. Pathology of lung cancer. In: J. Aisner, R. Arriagada, M. Green, N. Martini, and M. Perry (eds.), Comprehensive Textbook of Thoracic Oncology, pp. 245-275. Baltimore, MD: Williams & Wilkins, 1996.
3. Kwiatkowski, D. J., Harpole, D. H. J., Godleski, J., Herndon, J. E., Shieh, D. B., Richards, W., Blanco, R., Xu, H. J., Strauss, G. M., and Sugarbaker, D. J. Molecular-pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications. J. Clin. Oncol., 16: 2468-3477, 1998.
4. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Landers, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
5. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A-L., Brown, P. O., and Botstein, D. Molecular portraits of human breast tumours. Nature (Lond.), 406: 747-752, 2000.
6. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O-P., Wilfond, B., Borg, A., and Trent, J. Gene expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
7. Khan, J., Wei, J. S., Ringner, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., and Meltzer, P. S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7: 673-679, 2001.
8. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., and Hampton, G. M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61: 5974-5978, 2001.
9. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond.), 412: 822-826, 2001.
10. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
11. Beer, D. G., Kardia, S. L. R., Huang, C-C., Giordana, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G. Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M. G., Iannettoni, M. D., Orringer, M. B., and Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8: 816-824, 2002.
12. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma sub-classes. Proc. Natl. Acad. Sci. USA, 98: 13790-13795, 2001.
13. Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 99: 13784-13789, 2002.
14. Gordon, G. J., Jensen, R. V., Hsiao, L-L., Gullans, S. R., Blumenstock, J. E., Ramaswami, S., Richards, W. G., Sugarbaker, D. J., and Bueno, R. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res., 62: 4963-4967, 2002.
15. Gordon, G. J., Hsiao, L-L., Jensen, R. V., Gullans, S. R., Blumenstock, J. E., Richards, W. G., Sugarbaker, D. J., and Bueno, R. Using gene expression ratios to predict outcome among patients with mesothelioma. J. Natl. Cancer Inst. (Bethesda), 95: 598-6058, 2003.
16. Dudoit, S., Fridlyand, J., and Speed, T. P. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc., 97: 77-87, 2002.
17. Venables, W. N., and Riley, B. D. Modern Applied Statistics with S-Plus. New York, NY: Springer, 1997.
18. Russo, J., Hu, Y. F., Silva, I. D., and Russo, I. H. Cancer risk related to mammary gland structure and development. Microsc. Res. Tech., 52: 204-223, 2001.
19. Guerreiro Da Silva, I. D., Hu, Y. F., Russo, I. H., Ao, X., Salicioni, A. M., Yang, X., and Russo, J. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int. J. Oncol., 16: 231-240, 2000.
20. Hough, C. D., Sherman-Baust, C. A., Pizer, E. S., Montz, F. J., Im, D. D., Rosenshein, N. B., Cho, K. R., Riggins, G. J., and Morin, P. J. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res., 60: 6281-6287, 2000.
21. Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R., and Morin, P. J. Coordinately up-regulated genes in ovarian cancer. Cancer Res., 61: 3869-3876, 2001.
22. Mousses, S., Bubendorf, L., Wagner, U., Hostetter, G., Kononen, J., Cornelison, R., Goldberger, N., Elkahloun, A. G., Willi, N., Koivisto, P., Ferhle, W., Raffeld, M., Sauter, G., and Kallioniemi, O. P. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res., 62: 1256-1260, 2002.
23. Kalir, T., Wang, B. Y., Goldfischer, M., Haber, R. S., Reder, I., Demopoulos, R., Cohen, C. J., and Burstein, D. E. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia. Cancer (Phila.), 94: 1078-1082, 2002.
24. Chen, Y. Q., Zhou, Y. Q., Fisher, J. H., and Wang, M. H. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogene, 21: 6382-6386, 2002.
25. Ramaswamy, S., Ross, K. N., Lander, E. S., and Golub, T. A molecular signature of metastasis in primary solid tumors. Nat. Genet., 33: 49-54, 2002.
26. Li, H., Boiselle, P., Shepard, J., Trotman-Dickensno, B., and McLoud, T. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. Am. J. Roentgenol., 167: 105-109, 1996.
27. Bueno, R., Richards, W. G., Swanson, S. J., Jaklitsch, M. T., Lukanich, J., Mentzer, S. J., and Sugarbaker, D. J. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann. Thorac. Surg., 70: 1826-1831, 2000.
28. Bueno, R., Deters, L. A., Nitz, M. D., Lieberman, B. C., Gordon, G. J., Differential diagnosis of solitary lung nodules using gene expression ratios, submitted for publication.